Updated
REGENXBIORGNX · Healthcare
$7.62+3.25%
Market cap$504M
IndustryBiotechnology
REGENXBIO (RGNX) Superinvestor holders
9 of the superinvestors we track hold REGENXBIO (RGNX) in their latest 13F filings, $54M in total.
Summary
The largest holder is Cliff Asness (AQR Capital Management), with $17M, 0.0% of the portfolio.
In their latest quarter: 2 opened a new position, 4 added, 2 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
Added | 1,378,358 | $17M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
New position | 1,284,950 | $15M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 712,814 | $9M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 669,808 | $8M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 256,686 | $3M | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
New position | 138,558 | $1M | 0.0% | Q3 2026 |
| Alan Howard Brevan Howard |
Added | 33,177 | $397,460 | 0.0% | Q2 2026 |
| Didric Cederholm Lion Point Capital |
Held | 26,600 | $318,668 | 1.5% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 23,854 | $285,771 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 8 |
| Q1 2026 | 11 |
| Q4 2025 | 13 |
| Q3 2025 | 9 |
| Q2 2025 | 9 |
| Q1 2025 | 12 |
| Q4 2024 | 10 |
| Q3 2024 | 11 |
Questions about REGENXBIO
Which superinvestors own REGENXBIO?
9 of the superinvestors we track hold REGENXBIO (RGNX) in their latest 13F filings, $54M in total. Cliff Asness, Paul Marshall, David Shaw, Two Sigma, Jim Simons, Acadian.
Who is the largest superinvestor holder of RGNX?
The largest holder is Cliff Asness (AQR Capital Management), with $17M, 0.0% of the portfolio.
From REGENXBIO's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.